Life Molecular Imaging – Website

Innovative PET imaging agents for earlier and improved diagnosis and better characterization of diseases

Search Icon

Menu Toggle Icon

Skip to content
  • Home
  • About us
    • Leadership Team
    • Partners
    • Business Development & Licensing
    • Compliance & Code of Conduct
    • Contacts
  • Molecular Imaging
    • How It Works
    • Value of Molecular Imaging
  • Research & Development
    • Neuro-Imaging
    • Onco-Imaging
    • Cardiovascular-Imaging
  • Products
  • News
    • Current News
    • Careers

Life Molecular Imaging and XingImaging Announce PI-2620 Tau PET Tracer Production in Mainland China

26. October 201826. October 2018lifemolecular

Readmore: Life Molecular Imaging (LMI) and XingImaging announced that production of LMI’s 18F-labeled Tau PET imaging agent PI-2620 has commenced at XingImaging sites in China. 

Life Molecular Imaging and SOFIE announce PI-2620 Tau PET Tracer Production in SOFIE Radiopharmacy Network

13. September 201813. September 2018lifemolecular

Readmore: PI-2620 Tau PET tracer production for clinical trial supply has commenced in SOFIE Radiopharmacy Network

Piramal Imaging becomes Life Molecular Imaging

27. August 201827. August 2018lifemolecular

Readmore: Following the recent acquisition by Alliance Medical Group, Piramal Imaging is being renamed Life Molecular Imaging

Alliance Medical completes the purchase of Piramal Imaging

26. June 201821. August 2018lifemolecular

Readmore: Alliance-Medical-completes-the-purchase-of-Piramal-Imaging

Posts navigation

Newer posts →
© Copyright 2018 Life Molecular Imaging
Data Protection & Cookies. Our site uses cookies.
Click here to learn more: Data protection
Imprint / Data protection
Contact
Scroll to Top